VICENTE ANIDO JR Insider Trading $AERI AERIE PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VICENTE ANIDO JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VICENTE ANIDO JR. VICENTE ANIDO JR is Director in DEPOMED INC ($DMI) and President & CEO in ISTA PHARMACEUTICALS INC ($ISTA) and Chief Executive Officer in AERIE PHARMACEUTICALS INC ($AERI).
VICENTE ANIDO JR in AERIE PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VICENTE ANIDO JR: Chief Executive Officer
Holdings: 233,396 shares
Current Value: $9,989,349
Latest Transaction: Feb 25 2021
$AERI Market Capitalization: $1.50B
$AERI Previous Close: $42.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VICENTE ANIDO JR in AERIE PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AERI, DMI, ISTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 15.66 | 1,700 | 26,622 | 233,396 | 235.1 K to 233.4 K (-0.72 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.72 | 2,500 | 44,300 | 235,096 | 237.6 K to 235.1 K (-1.05 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,496 | 44,129 | 237,596 | 240.1 K to 237.6 K (-1.04 %) |
| Feb 09 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 17.68 | 2,958 | 52,297 | 240,092 | 243.1 K to 240.1 K (-1.22 %) |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 17.64 | 125,000 | 2,205,000 | 125,000 | |
| Feb 08 2021 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 243,050 | 215.1 K to 243.1 K (+13.02 %) |
| May 18 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 14.85 | 4,746 | 70,454 | 215,050 | 219.8 K to 215.1 K (-2.16 %) |
| Feb 25 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.30 | 1,527 | 30,998 | 219,796 | 221.3 K to 219.8 K (-0.69 %) |
| Feb 25 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 21.59 | 1,052 | 22,713 | 221,323 | 222.4 K to 221.3 K (-0.47 %) |
| Feb 11 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.49 | 1,546 | 31,678 | 222,375 | 223.9 K to 222.4 K (-0.69 %) |
| Feb 11 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 20.49 | 1,710 | 35,038 | 223,921 | 225.6 K to 223.9 K (-0.76 %) |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 21.18 | 125,000 | 2,647,500 | 125,000 | |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 225,631 | 197.6 K to 225.6 K (+14.17 %) |
| Feb 10 2020 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | W | 0.00 | 2,250 | 0 | 10,500 | 8.3 K to 10.5 K (+27.27 %) |
| Sep 09 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | P | 19.95 | 2,000 | 39,900 | 197,631 | 195.6 K to 197.6 K (+1.02 %) |
| Sep 09 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | P | 18.93 | 24,250 | 459,053 | 195,631 | 171.4 K to 195.6 K (+14.15 %) |
| May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.54 | 4,145 | 168,038 | 171,381 | 175.5 K to 171.4 K (-2.36 %) |
| May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 32,171 | 0 | 175,526 | 143.4 K to 175.5 K (+22.44 %) |
| Apr 15 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 41.89 | 2,612 | 109,417 | 143,355 | 146 K to 143.4 K (-1.79 %) |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 43.07 | 114,358 | 4,925,399 | 114,358 | |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.39 | 1,624 | 65,593 | 150,109 | 151.7 K to 150.1 K (-1.07 %) |
| Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 151,733 | 126.3 K to 151.7 K (+20.12 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 50,000 | 157,500 | 846,329 | |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.92 | 4,996 | 314,350 | 126,320 | 131.3 K to 126.3 K (-3.80 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.90 | 45,004 | 2,785,946 | 131,316 | 176.3 K to 131.3 K (-25.52 %) |
| Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 50,000 | 157,500 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 26,139 | 82,338 | 896,329 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 23,861 | 69,197 | 0 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 23,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 73,861 | |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 64.52 | 29,717 | 1,917,362 | 126,320 | 156 K to 126.3 K (-19.04 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 63.35 | 20,283 | 1,284,924 | 156,037 | 176.3 K to 156 K (-11.50 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 26,139 | 82,338 | 176,320 | 150.2 K to 176.3 K (+17.40 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 23,861 | 69,197 | 150,181 | 126.3 K to 150.2 K (+18.89 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.80 | 16,386 | 1,029,092 | 126,320 | 142.7 K to 126.3 K (-11.48 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.06 | 33,614 | 2,085,957 | 142,706 | 176.3 K to 142.7 K (-19.06 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.10 | 4,338 | 265,044 | 126,320 | 130.7 K to 126.3 K (-3.32 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 60.44 | 45,662 | 2,760,003 | 130,658 | 176.3 K to 130.7 K (-25.90 %) |
| Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,351 | 72,751 | 126,320 | 127.7 K to 126.3 K (-1.06 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 2,054 | 110,608 | 127,671 | 129.7 K to 127.7 K (-1.58 %) |
| May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,052 | 56,650 | 129,725 | 130.8 K to 129.7 K (-0.80 %) |
| Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.40 | 3,149 | 168,157 | 130,777 | 133.9 K to 130.8 K (-2.35 %) |
| Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 21,448 | 0 | 133,926 | 112.5 K to 133.9 K (+19.07 %) |
| Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 53.55 | 114,358 | 6,123,871 | 114,358 | |
| Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 112,478 | 87.1 K to 112.5 K (+29.19 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 44.25 | 155,528 | 6,882,114 | 155,528 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,518 | 67,627 | 87,065 | 88.6 K to 87.1 K (-1.71 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,716 | 76,448 | 88,583 | 90.3 K to 88.6 K (-1.90 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 17,281 | 0 | 90,299 | 73 K to 90.3 K (+23.67 %) |
| Mar 01 2016 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 16.69 | 150,504 | 2,511,912 | 150,504 | |
| Mar 01 2016 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,085 | 0 | 75,273 | 50.2 K to 75.3 K (+49.98 %) |
| Feb 27 2015 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 28.03 | 133,125 | 3,731,494 | 133,125 | |
| Feb 27 2015 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 22,188 | 0 | 50,188 | 28 K to 50.2 K (+79.24 %) |
Page: 1